Exacerbation of group B streptococcal sepsis and arthritis in diabetic mice

Microbes and Infection

Volumn 8, Issue 9-10, 2006, Pages 2376-2383

  Puliti, Manuela ^a   Bistoni, Francesco ^a   Orefici, Graziella ^b   Tissi, Luciana ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Diabetes; Group B streptococci; Inflammation; Septic arthritis

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; HOST PATHOGEN INTERACTION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS AGALACTIAE;

ANIMALS; ARTHRITIS; BACTEREMIA; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINE CXCL2; CHEMOKINES; DIABETES MELLITUS, EXPERIMENTAL; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGE INFLAMMATORY PROTEIN-1; MACROPHAGE INFLAMMATORY PROTEINS; MALE; MICE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; STREPTOCOCCUS SP. 'GROUP B';

EID: 33749358081     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.04.021     Document Type: Article

References (30)

1. Schuchat A. Group B streptococcus. Lancet 353 (1999) 51-56
2. Farley M.M. Group B streptococcal disease in nonpregnant adults. Clin. Infect. Dis. 33 (2001) 556-561
3. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11 (1998) 497-513
4. Tan J.S. Infectious complications in patients with diabetes mellitus. Int Diabet. Monit. 12 (2000) 1-7
5. Leibovici L., Yehehzkelli Y., Porter A., Regev A., Krauze I., and Harrell D. Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections. Diabetic Med. 13 (1996) 457-463
6. Small C.B., Slater L.M., Lowy F.D., Small R.D., Salvati E.A., and Casey J.I. Group B streptococcal arthritis in adults. Am. J. Med 76 (1984) 367-375
7. Laster A.J., and Michels M.L. Group B streptococcal arthritis in adults. Am. J Med. 76 (1984) 910-915
8. Nolla J.M., Gomez-Vaquero C., Corbella X., Ordonez S., Garcia-Gomez C., Perez A., Cabo J., Valverde J., and Ariza J. Group B streptococcus (Streptococcus agalactiae) pyogenic arthritis in nonpregnant adults. Medicine 82 (2003) 119-128
9. Dubost J.J., Soubrier M., De Champs C., Ristori J.M., and Sauvezie B. Streptococcal septic arthritis in adults. A study of 55 cases with a literature review. Joint Bone Spine 71 (2004) 303-311
10. Tissi L., Marconi P., Mosci P., Merletti L., Cornacchione P., Rosati E., Recchia S., von Hunolstein C., and Orefici G. Experimental model of type IV Streptococcus agalactiae (group B Streptococcus) infection in mice with early development of septic arthritis. Infect. Immun. 58 (1990) 3093-3100
11. Tissi L., von Hunolstein C., Bistoni F., Marangi M., Parisi L., and Orefici G. Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis. J. Med. Microbiol. 47 (1998) 717-723
12. Puliti M., Nizet V., von Hunolstein C., Bistoni F., Mosci P., Orefici G., and Tissi L. Severity of group B streptococcal arthritis is correlated with β-hemolysin expression. J. Infect. Dis. 182 (2000) 824-832
13. Puliti M., von Hunolstein C., Bistoni F., Castronari R., Orefici G., and Tissi L. Role of macrophages in experimental group B streptococcal arthritis. Cell. Microbiol. 4 (2002) 691-700
14. Tissi L., Puliti M., Barluzzi R., Orefici G., von Hunolstein C., and Bistoni F. Role of tumor necrosis factor alpha, interleukin-1β and interleukin-6 in a mouse model of group B streptococcal arthritis. Infect. Immun. 67 (1999) 4545-4550
15. Reed L.J., and Muench H. A simple method of estimating fifty per cent end-points. Am. J. Hyg. 27 (1938) 493-497
16. Moutschen M.P., Scheen A.J., and Lefebvre P.J. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Diabetes Metab. 18 (1992) 187-201
17. Edwards M.S., and Fuselier P.A. Enhanced susceptibility of mice with streptozotocin-induced diabetes to type II group B streptococcal infection. Infect. Immun. 39 (1983) 580-585
18. Gallacher S.J., Thompson G., Fraser W.D., Fisher B.M., Gemmel C.G., and MacCuish A.C. Neutrophil bactericidal functions in diabetes mellitus: evidence for association with blood glucose control. Diabet. Med. 12 (1995) 916-920
19. Mazade M.A., and Edwards M.S. Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes. Mol. Genet. Metab. 73 (2001) 259-267
20. Sen P., Bhattacharyya S., Wallet M., Wong C.P., Polignone B., Sen M., Baldwin Jr. A.S., and Tisch R. NF-kB hyperactivation has differential effects on the APC functions of nonobese diabetic mouse macrophages. J. Immunol. 170 (2003) 1770-1780
21. Yamashiro S., Kawakami K., Uezu K., Kinjo T., Miyagi K., Nakamura K., and Saito A. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin. Exp. Immunol. 139 (2005) 57-64
22. Mosci P., Vecchiarelli A., Cenci E., Puliti M., and Bistoni F. Low-dose streptozotocin-induced diabetes in mice. I. Course of Candida albicans infection. Cell. Immunol. 150 (1993) 27-35
23. Puliti M., von Hunolstein C., Bistoni F., Mosci P., Orefici G., and Tissi L. Influence of interferon-γ administration on the severity of experimental group B streptococcal arthritis. Arthritis Rheum. 43 (2000) 2678-2686
24. Cusumano V., Mancuso G., Genovese F., Delfino D., Beninati C., Losi E., and Teti G. Role of gamma interferon in a neonatal mouse model of group B streptococcal disease. Infect. Immun. 64 (1996) 2941-2944
25. van de Loo F.A.J., Joosten L.A.B., van Lent P.L.E.M., Arntz O.J., and van den Berg W.B. Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Arthritis Rheum. 38 (1995) 164-172
26. Naguib G., Al-Mashat H., Desta T., and Graves D.T. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J. Invest. Dermatol. 123 (2004) 87-92
27. Peters K.M., Koberg K., Rosendahl T., Klosterhalfen B., Straub A., and Zwaldo-Klarwasser G. Macrophage reaction in septic arthritis. Arch. Ortop. Trauma Surg 115 (1996) 347-350
28. Graves D.T., Naguib G., Lu H., Leone C., Hsue H., and Krall E. Inflammation is more persistent in type 1 diabetic mice. J. Dent. Res. 84 (2005) 324-328
29. Geerlings S.E., Brouwer E.C., Van Kessel K.C., Gaastra W., Stolk R.P., and Hoepelman A.L. Cytokine secretion is impaired in women with diabetes mellitus. Eur. J. Clin. Invest 30 (2000) 995-1001
30. Bouma G., Nikolic T., Coppens J.M., van Helden-Meeuwsen C.G., Leenen P.J., Drexhage H.A., Sozzani S., and Versnel M.A. NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation. Eur. J. Immunol. 35 (2005) 225-235